But first… what is EPI?

Exocrine Pancreatic Insufficiency (EPI) is a chronic condition in which the pancreas fails to produce enough digestive enzymes (lipase, amylase, proteases). As a result, the body cannot properly absorb nutrients, leading to progressive weakness and a significantly reduced quality of life.

Today, treatment relies on standard enzyme replacement therapy.

But EN311, our innovative candidate, could change everything.

Designed to enhance the effectiveness of enzyme supplementation, EN311 aims to deliver superior performance, improved nutrient absorption, and better quality of life for patients.

EN311 should open an new era in EPI treatment, a promising step forward for everyone living with EPI !